Data gathered: November 27
AI Stock Analysis - Pluri (PLUR)
Analysis generated March 13, 2024. Powered by Chat GPT.
Pluri is a high-growth company with a mission to provide innovative solutions in its industry. Although specific details about the company's operations, market footprint, and strategic focus are not provided in the prompt, it is safe to assume that Pluri's recent performance illustrates a trajectory of growth and expansion. With rapid year-over-year revenue increases and a notable quarter-to-quarter performance, Pluri seems to be successfully scaling operations and penetrating markets efficiently.
Stock Alerts - Pluri (PLUR)
 |
Pluri | November 27 Price is up by 5.1% in the last 24h. |
|
Pluri | November 26 Price is up by 5.2% in the last 24h. |
|
Pluri | November 25 Price is up by 10.6% in the last 24h. |
|
Pluri | November 21 Price is down by -7.5% in the last 24h. |
Alternative Data for Pluri
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 85 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Google Trends | 30 | Sign up | Sign up | Sign up |
| Patents | 25 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,395 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,725 | Sign up | Sign up | Sign up |
| Twitter Mentions | 32 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 401 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 204 | Sign up | Sign up | Sign up |
About Pluri
Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions.
| Price | $5.57 |
| Target Price | Sign up |
| Volume | 120,390 |
| Market Cap | $29M |
| Year Range | $4.32 - $8.16 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat ConcernsNovember 24 - Yahoo |
 |
Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)November 14 - Yahoo |
 |
Pluri: Fiscal Q1 Earnings SnapshotNovember 12 - Yahoo |
 |
BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial ManufacturingNovember 10 - Yahoo |
|
Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation AuthorityOctober 27 - Yahoo |
Pluri collaborates with Bar-Ilan University to advance cancer immunotherapyOctober 27 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 330,000 | 130,000 | 200,000 | -5.9M | 0 | 0.000 |
| Q2 '24 | 96,000 | -7.3M | 7.4M | -5.7M | -5.6M | -1.059 |
| Q1 '24 | 71,000 | 2.5M | -2.4M | -5.3M | -5.5M | -1.014 |
| Q4 '23 | 110,000 | 2.4M | -2.2M | -4.9M | -11M | -0.118 |
| Q3 '23 | 54,000 | 2.4M | 54,000 | -5M | -11M | -0.190 |
Insider Transactions View All
| Aberman Zami filed to sell 1,491,973 shares at $1. December 22 '22 |
| Aberman Zami filed to buy 91,756 shares at $1.8. February 14 '22 |
Similar companies
Read more about Pluri (PLUR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Pluri?
The Market Cap of Pluri is $29M.
What is the current stock price of Pluri?
Currently, the price of one share of Pluri stock is $5.57.
How can I analyze the PLUR stock price chart for investment decisions?
The PLUR stock price chart above provides a comprehensive visual representation of Pluri's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pluri shares. Our platform offers an up-to-date PLUR stock price chart, along with technical data analysis and alternative data insights.
Does PLUR offer dividends to its shareholders?
As of our latest update, Pluri (PLUR) does not offer dividends to its shareholders. Investors interested in Pluri should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Pluri?
Some of the similar stocks of Pluri are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.